Effectiveness and safety of the monoclonal antibody drug lecanemab (Leqembi) in reducing beta-amyloid plaques in alzheimer’s dementia: a literature review. JOHMPE [Internet]. 2025 Feb. 27 [cited 2026 Aug. 24];3(1). Available from: https://shmpublisher.com/index.php/johmpe/article/view/547